Delivery Order SPE2DB22D2211-SPE2DB24FMLC6

Award Date 12/21/23
Potential Completion Date 12/22/23
Potential Value $1.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,126.44, is for the delivery of NEOMYC-POLYM-GRAMICID eye drops in 10 milliliter vials. The award has a completion date of January 7, 2025 and is a firm fixed-price contract. Amerisourcebergen holds a broader $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Neomycin-Polymyxin-Dexamethasone eye drops with a ceiling value of $1,392.27. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a potential value of up to $999,999,999 for providing a comprehensive range of medical commodities to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,599.07 firm fixed-price delivery order is for the supply of NEOMYC-POLYM-GRAMICID EYE DROP 10ML, a type of prescription medication. The contract has an ultimate completion date of September 27, 2024. Amerisourcebergen, through its Corporate Office division, has been awarded this contract without any set-aside designation. The company holds...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the supply of Neomycin-Polymyxin-Hydrocortisone eye drops. The contract has a total ceiling value of $3,088.52 and an ultimate completion date of August 9, 2024. Amerisourcebergen, a major pharmaceutical distributor, provides a wide range of medical products and supplies to support various government agencies and healthcare programs, including...
This is a $1,354.91 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NEOMYC-POLYM-GRAMICID EYE DROP 10ML, a medical product. The contract has a period of performance through January 17, 2024. This contract award is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA...
The Defense Logistics Agency awarded a $557.76 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561569094 NEOMYCIN-POLY-HC eye drops. As the prime contractor, Amerisourcebergen will supply 7.5mL bottles of the antibiotic ophthalmic solution to the DLA from its facility in Conshohocken, Pennsylvania, with performance required between July 21-24, 2023. No subcontractors or set aside designations were indicated. The order is likely associated with the DLA's medical...
The federal contract award is for the delivery of Olopatadine HCL 0.1% eye drops, 5 mL, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $1,723.35 and is a firm fixed-price delivery order contract. There is no set-aside designation mentioned in the award details. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $9,535.81 delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The award is for the supply of Fluorometholone 0.1% eye drops, a pharmaceutical product used to treat various eye conditions. There is no set-aside designation, indicating this was an open competition. The DLA, a defense agency, is the...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of NEOMYCIN-POLYMYXIN-HC EAR SUSPENSION, a pharmaceutical product, with a ceiling value of $10,968.20 and a completion date of February 13, 2024. The contract is a delivery order and is priced as a firm fixed price. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999...
This federal contract award, valued at $3,003.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of NEOMYC-BACIT-POLYMIX EYE OINT 3.5GM, a pharmaceutical product. The contract has an ultimate completion date of February 27, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor for this award. The company...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB24FMLC6
    Delivery Order

This federal contract award is for the delivery of Neomycin-Poly-HC eye drops, 7.5 mL, to the Defense Logistics Agency (DLA). The contract, valued at $1,143.07, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract award does not have a set-aside designation, indicating it was awarded through full and open competition.

Generated 5/13/25, 9:48 AM